Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva
NCT01022931 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2012-12-11
Summary
This study aims to identify clinical symptoms and outcomes, as well as response to anti-viral treatment in children living in Geneva, with influenza A/ H1N1 infection during the current pandemic.
Conditions
- Healthy
- Immunosuppressed
- Asthmatic
- Neuromuscular Diseases
Sponsors & Collaborators
-
University Hospital, Geneva
lead OTHER
Principal Investigators
-
Klara M Posfay-Barbe, MD, MS · University Hospitals of Geneva
Eligibility
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-10-31
- Primary Completion
- 2010-02-28
- Completion
- 2012-07-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants
NCT01494740 ·Status: COMPLETED ·Phase: PHASE2
-
A/H5N1 Vaccine in Healthy Children Aged 2-9 Years
NCT00133536 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months
NCT00996307 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Surveillance of Influenza Virus Among Children With Febrile Respiratory Complaints Attending the Pediatric Clinic of the First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, Mainland China
NCT00760500 ·Status: COMPLETED
-
Prospective Analysis of Seasonal Influenza - Viral Transmission and Evolution in the City of Basel, Switzerland
NCT03010007 ·Status: COMPLETED
-
Swine Flu (Novel Influenza A H1N1) Vaccine Study
NCT00980850 ·Status: COMPLETED ·Phase: PHASE2
-
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month
NCT01040078 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of Moderate to Severe Influenza Outcomes in Children
NCT02979626 ·Status: COMPLETED
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children
NCT01776554 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective System Analysis of the Seasonal Influenza Virus Transmissions and Evolution in the City of Basel Basel
NCT03451656 ·Status: COMPLETED
-
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children
NCT00972517 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children
NCT00900991 ·Status: COMPLETED ·Phase: PHASE2
-
Promotion of Influenza Vaccination in Healthcare Workers During the Recruitment Visit
NCT02758145 ·Status: COMPLETED ·Phase: NA
-
A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents
NCT00976469 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years
NCT00952419 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents
NCT01052402 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
NCT02915302 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children
NCT00884182 ·Status: COMPLETED ·Phase: PHASE2
-
Japanese Pediatric H5N1 Vaccine Study
NCT01911754 ·Status: COMPLETED ·Phase: PHASE3
-
Influenza Immunity in Children
NCT02559505 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years
NCT00537524 ·Status: COMPLETED ·Phase: PHASE2
-
Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge Strain
NCT05572450 ·Status: COMPLETED ·Phase: NA
-
Novartis H1N1 Vaccine in Pregnant Women
NCT00992719 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Investigation on Allergic-like Reactions and Oculo-respiratory Syndrome After the H1N1 Pandemic Vaccine
NCT01247415 ·Status: UNKNOWN
-
Safety, Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)
NCT00971321 ·Status: COMPLETED ·Phase: PHASE2